C-glucuronides
C-glucuronides - Related Videos
01:24
Phase II Reactions: Glucuronidation
0 Views •
2025
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
08:56
Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
0 Views •
Cited by 1 •
2022
The present protocol describes a detailed benchtop catalytic method that yields a unique borylated derivative of...
12:34
Isolation and Staining of Mouse Skin Keratinocytes for Cell Cycle Specific Analysis of Cellular Protein Expression by Mass Cytometry
0 Views •
Cited by 2 •
2019
This protocol describes how to isolate skin keratinocytes from mouse models, to stain with metal-tagged antibodies, and to analyze stained cells by mass cytometry in order to profile the expression pattern of proteins of interest in the different cell cycle phases.
09:06
Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate
0 Views •
Cited by 8 •
2020
Here, we describe a growth condition to culture the small colony variant of Pseudomonas aeruginosa. We also describe two separate methods for the detection and quantitation of the exopolysaccharide alginate produced by P. aeruginosa using a traditional uronic acid carbazole assay and an alginate-specific monoclonal antibody (mAb) based ELISA.
08:57
Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis
0 Views •
Cited by 13 •
2014
Here we describe a protocol using the mini-himar1 mariner transposon-mediated mutagenesis for generating a high-density insertion mutant library to screen, isolate and identify novel alginate regulators in the prototypic Pseudomonas aeruginosa strain PAO1.
FAQs
The carbon–carbon linkage makes these conjugates more chemically stable than oxygen-linked glucuronides, which are more readily hydrolyzed. This difference can affect how long a metabolite remains intact during biotransformation and sample analysis. In clinical pharmacology, greater stability helps explain why a metabolite may persist, influence measured exposure, and require specific consideration when evaluating drug disposition.
Formation depends on enzyme-mediated glucuronidation in which UDP-glucuronic acid donates glucuronic acid to the drug or other molecule. The resulting attachment occurs through carbon rather than oxygen, producing a structural outcome that differs from conventional O-linked glucuronides. This distinction is important because the linkage type influences chemical behavior and the subsequent interpretation of metabolite stability.
Their stability can change the apparent fate of a drug-derived metabolite after formation. By resisting hydrolysis more effectively than oxygen-linked conjugates, C-glucuronides may affect metabolic clearance, measured pharmacokinetic profiles, and the duration for which a biotransformation product is detectable. These effects help researchers determine whether conjugation primarily alters exposure, removes biological activity, or preserves a relevant metabolite.
The principal difference is the atom and bond connecting glucuronic acid to the substrate. C-glucuronides contain a stable carbon–carbon connection, whereas oxygen-linked glucuronides are more readily hydrolyzed. Consequently, the two metabolite classes may behave differently during metabolic clearance and clinical sample analysis, so researchers must account for linkage-specific stability when interpreting biotransformation results.
Researchers need analytical methods that account for the conjugates' stable structure and potential persistence in samples. Detection is relevant not only for confirming that a medicine undergoes glucuronidation, but also for measuring its biotransformation products accurately. Reliable analysis supports interpretation of metabolite exposure and reduces the risk that stability-related behavior will obscure clinically important findings.
Studying these metabolites helps researchers determine whether a drug-derived conjugate has consequences beyond simple metabolic clearance. Measurements can contribute to assessments of metabolite safety and efficacy, while the clinical pharmacology context helps relate those findings to drug disposition and biological activity. This information supports a more complete evaluation of medicines and their biotransformation products.